Go to JCI Insight
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Publication alerts by email
  • Advertising
  • Job board
  • Contact
  • Clinical Research and Public Health
  • Current issue
  • Past issues
  • By specialty
    • COVID-19
    • Cardiology
    • Gastroenterology
    • Immunology
    • Metabolism
    • Nephrology
    • Neuroscience
    • Oncology
    • Pulmonology
    • Vascular biology
    • All ...
  • Videos
    • Conversations with Giants in Medicine
    • Video Abstracts
  • Reviews
    • View all reviews ...
    • Pancreatic Cancer (Jul 2025)
    • Complement Biology and Therapeutics (May 2025)
    • Evolving insights into MASLD and MASH pathogenesis and treatment (Apr 2025)
    • Microbiome in Health and Disease (Feb 2025)
    • Substance Use Disorders (Oct 2024)
    • Clonal Hematopoiesis (Oct 2024)
    • Sex Differences in Medicine (Sep 2024)
    • View all review series ...
  • Viewpoint
  • Collections
    • In-Press Preview
    • Clinical Research and Public Health
    • Research Letters
    • Letters to the Editor
    • Editorials
    • Commentaries
    • Editor's notes
    • Reviews
    • Viewpoints
    • 100th anniversary
    • Top read articles

  • Current issue
  • Past issues
  • Specialties
  • Reviews
  • Review series
  • Conversations with Giants in Medicine
  • Video Abstracts
  • In-Press Preview
  • Clinical Research and Public Health
  • Research Letters
  • Letters to the Editor
  • Editorials
  • Commentaries
  • Editor's notes
  • Reviews
  • Viewpoints
  • 100th anniversary
  • Top read articles
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Publication alerts by email
  • Advertising
  • Job board
  • Contact

Citations to this article

Polyvariant mutant cystic fibrosis transmembrane conductance regulator genes. The polymorphic (Tg)m locus explains the partial penetrance of the T5 polymorphism as a disease mutation.
H Cuppens, … , B Nilius, J J Cassiman
H Cuppens, … , B Nilius, J J Cassiman
Published January 15, 1998
Citation Information: J Clin Invest. 1998;101(2):487-496. https://doi.org/10.1172/JCI639.
View: Text | PDF
Research Article Article has an altmetric score of 19

Polyvariant mutant cystic fibrosis transmembrane conductance regulator genes. The polymorphic (Tg)m locus explains the partial penetrance of the T5 polymorphism as a disease mutation.

  • Text
  • PDF
Abstract

In congenital bilateral absence of the vas deferens patients, the T5 allele at the polymorphic Tn locus in the CFTR (cystic fibrosis transmembrane conductance regulator) gene is a frequent disease mutation with incomplete penetrance. This T5 allele will result in a high proportion of CFTR transcripts that lack exon 9, whose translation products will not contribute to apical chloride channel activity. Besides the polymorphic Tn locus, more than 120 polymorphisms have been described in the CFTR gene. We hypothesized that the combination of particular alleles at several polymorphic loci might result in less functional or even insufficient CFTR protein. Analysis of three polymorphic loci with frequent alleles in the general population showed that, in addition to the known effect of the Tn locus, the quantity and quality of CFTR transcripts and/or proteins was affected by two other polymorphic loci: (TG)m and M470V. On a T7 background, the (TG)11 allele gave a 2.8-fold increase in the proportion of CFTR transcripts that lacked exon 9, and (TG)12 gave a sixfold increase, compared with the (TG)10 allele. T5 CFTR genes derived from patients were found to carry a high number of TG repeats, while T5 CFTR genes derived from healthy CF fathers harbored a low number of TG repeats. Moreover, it was found that M470 CFTR proteins matured more slowly, and that they had a 1.7-fold increased intrinsic chloride channel activity compared with V470 CFTR proteins, suggesting that the M470V locus might also play a role in the partial penetrance of T5 as a disease mutation. Such polyvariant mutant genes could explain why apparently normal CFTR genes cause disease. Moreover, they might be responsible for variation in the phenotypic expression of CFTR mutations, and be of relevance in other genetic diseases.

Authors

H Cuppens, W Lin, M Jaspers, B Costes, H Teng, A Vankeerberghen, M Jorissen, G Droogmans, I Reynaert, M Goossens, B Nilius, J J Cassiman

×

Total citations by year

Year: 2025 2024 2023 2022 2021 2020 2019 2018 2017 2016 2015 2014 2013 2012 2011 2010 2009 2008 2007 2006 2005 2004 2003 2002 2001 2000 1999 1998 Total
Citations: 1 5 6 3 6 13 5 7 10 12 6 8 11 10 29 14 14 14 21 17 27 22 7 13 10 10 11 3 315
Citation information
This citation data is accumulated from CrossRef, which receives citation information from participating publishers, including this journal. Not all publishers participate in CrossRef, so this information is not comprehensive. Additionally, data may not reflect the most current citations to this article, and the data may differ from citation information available from other sources (for example, Google Scholar, Web of Science, and Scopus).

Citations to this article in year 2020 (13)

Title and authors Publication Year
CFTR targeted therapies: recent advances in cystic fibrosis and possibilities in other diseases of the airways
SD Patel, TR Bono, SM Rowe, GM Solomon
European Respiratory Review 2020
Nasal potential difference in suspected cystic fibrosis patients with 5T polymorphism
BL Aalbers, Y Yaakov, N Derichs, NJ Simmonds, ED Wachter, P Melotti, KD Boeck, T Leal, B Tümmler, M Wilschanski, I Bronsveld
Journal of Cystic Fibrosis 2020
CFTR Gene Variants and Genotypes in Russian Patients with CBAVD Syndrome
EG Marnat, TA Adyan, AA Stepanova, TS Beskorovainaya, AV Polyakov, VB Chernykh
Russian Journal of Genetics 2020
“Summer hypokalemia” as an initial presentation of cystic fibrosis in a morbidly obese African American adult: case report
Y Cao, R Donaldson, D Lee
BMC Nephrology 2020
Rescue of common exon‐skipping mutations in cystic fibrosis with modified U1 snRNAs
S Donegà, ME Rogalska, G Pianigiani, S Igreja, MD Amaral, F Pagani
Human Mutation 2020
The Cystic Fibrosis Transmembrane Conductance Regulator 470 Met Allele Is Associated with an Increased Risk of Chronic Pancreatitis in Both Asian and Caucasian Populations: A Meta-Analysis
D Zhou, R Bai, L Wang
Genetic Testing and Molecular Biomarkers 2020
Genetic markers for treatment-related pancreatitis in a cohort of Hispanic children with acute lymphoblastic leukemia
AC Grimes, Y Chen, H Bansal, C Aguilar, LP Prado, G Quezada, J Estrada, GE Tomlinson
Supportive Care in Cancer 2020
Cystic fibrosis gene mutations and polymorphisms in Saudi men with infertility
T AlMaghamsi, N Iqbal, NA Al-Esaei, M Mohammed, KZ Eddin, F Ghurab, N Moghrabi, E Heaphy, I Junaid
Annals of Saudi medicine 2020
Mutations of the cystic fibrosis transmembrane conductance regulator gene in males with congenital bilateral absence of the vas deferens: Reproductive implications and genetic counseling (Review)
X Cui, X Wu, Q Li, X Jing
Molecular medicine reports 2020
Haplotype analysis of the CFTR gene on normal and mutant CFTR genes
N Karimi, AB Pour, R Alibakhshi, S Almasi
Mutation research 2020
Genetics of the congenital absence of the vas deferens
E Bieth, SM Hamdi, R Mieusset
Human Genetics 2020
Prevalence of CBAVD in azoospermic men carrying pathogenic CFTR mutations ‐ Evaluated in a cohort of 639 non‐vasectomized azoospermic men
J Fedder, MW Jørgensen, B Engvad
Andrologia 2020
First custom next-generation sequencing infertility panel in Latin America: design and first results
D Lorenzi, C Fernández, M Bilinski, M Fabbro, M Galain, S Menazzi, M Miguens, PN Perassi, MF Fulco, S Kopelman, G Fiszbajn, F Nodar, S Papier
JBRA Assisted Reproduction 2020

Advertisement

Copyright © 2025 American Society for Clinical Investigation
ISSN: 0021-9738 (print), 1558-8238 (online)

Sign up for email alerts

Referenced in 2 policy sources
Referenced in 1 patents
On 1 Facebook pages
Referenced in 3 clinical guideline sources
94 readers on Mendeley
See more details